Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of activation of Janus kinase activity (GO:0010533) | 9.28446953 |
2 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 8.41599714 |
3 | hair cycle (GO:0042633) | 8.07689351 |
4 | molting cycle (GO:0042303) | 8.07689351 |
5 | retina homeostasis (GO:0001895) | 7.65530540 |
6 | purine nucleotide transport (GO:0015865) | 7.54402469 |
7 | T-helper 1 type immune response (GO:0042088) | 7.36404388 |
8 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 7.33029048 |
9 | positive regulation of chemokine secretion (GO:0090197) | 7.10242928 |
10 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 7.10196236 |
11 | linoleic acid metabolic process (GO:0043651) | 6.65195204 |
12 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 6.55179573 |
13 | positive regulation of keratinocyte differentiation (GO:0045618) | 6.55014309 |
14 | regulation of lipoprotein metabolic process (GO:0050746) | 6.36619238 |
15 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 6.34874648 |
16 | regulation of chemokine secretion (GO:0090196) | 6.20632051 |
17 | regulation of memory T cell differentiation (GO:0043380) | 6.19616615 |
18 | primary alcohol catabolic process (GO:0034310) | 5.98489138 |
19 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.97381921 |
20 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.83634077 |
21 | keratinization (GO:0031424) | 5.72549504 |
22 | negative regulation of adherens junction organization (GO:1903392) | 5.72465261 |
23 | negative regulation of focal adhesion assembly (GO:0051895) | 5.72465261 |
24 | negative regulation of cell junction assembly (GO:1901889) | 5.72465261 |
25 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.58271073 |
26 | negative regulation of bone mineralization (GO:0030502) | 5.44363401 |
27 | short-chain fatty acid metabolic process (GO:0046459) | 5.42384844 |
28 | establishment of skin barrier (GO:0061436) | 5.33920075 |
29 | regulation of water loss via skin (GO:0033561) | 5.28709469 |
30 | regulation of response to tumor cell (GO:0002834) | 5.28060857 |
31 | positive regulation of response to tumor cell (GO:0002836) | 5.28060857 |
32 | positive regulation of immune response to tumor cell (GO:0002839) | 5.28060857 |
33 | regulation of immune response to tumor cell (GO:0002837) | 5.28060857 |
34 | negative regulation of chemokine production (GO:0032682) | 5.24553617 |
35 | positive regulation of monocyte chemotaxis (GO:0090026) | 5.22029599 |
36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 5.20303865 |
37 | negative regulation of interleukin-17 production (GO:0032700) | 5.19972502 |
38 | sexual reproduction (GO:0019953) | 5.12131269 |
39 | defense response to protozoan (GO:0042832) | 5.11733593 |
40 | negative regulation of biomineral tissue development (GO:0070168) | 5.00356519 |
41 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 4.95435164 |
42 | positive regulation of interleukin-17 production (GO:0032740) | 4.92420427 |
43 | desmosome organization (GO:0002934) | 4.90710588 |
44 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.90494394 |
45 | positive regulation of defense response to virus by host (GO:0002230) | 4.89443837 |
46 | positive regulation of interleukin-12 production (GO:0032735) | 4.80638863 |
47 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.71588454 |
48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64009229 |
49 | positive regulation of type 2 immune response (GO:0002830) | 4.59774507 |
50 | lipoxygenase pathway (GO:0019372) | 4.49825843 |
51 | ethanol metabolic process (GO:0006067) | 4.45389062 |
52 | response to peptidoglycan (GO:0032494) | 4.43982770 |
53 | regulation of T-helper 1 type immune response (GO:0002825) | 4.42680513 |
54 | positive regulation of interferon-alpha production (GO:0032727) | 4.42454915 |
55 | adhesion of symbiont to host cell (GO:0044650) | 4.41246476 |
56 | virion attachment to host cell (GO:0019062) | 4.41246476 |
57 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.39757953 |
58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.39114197 |
59 | regulation of female receptivity (GO:0045924) | 4.32007081 |
60 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.31916227 |
61 | response to protozoan (GO:0001562) | 4.29241622 |
62 | regulation of T-helper cell differentiation (GO:0045622) | 4.27643201 |
63 | regulation of keratinocyte differentiation (GO:0045616) | 4.26055861 |
64 | neutrophil activation involved in immune response (GO:0002283) | 4.25567342 |
65 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 4.23390111 |
66 | axon regeneration (GO:0031103) | 4.21784362 |
67 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 4.21104228 |
68 | peptide cross-linking (GO:0018149) | 4.20429082 |
69 | negative regulation of leukocyte migration (GO:0002686) | 4.20417479 |
70 | benzene-containing compound metabolic process (GO:0042537) | 4.19256588 |
71 | immunoglobulin mediated immune response (GO:0016064) | 4.14362016 |
72 | regulation of interferon-alpha production (GO:0032647) | 4.10150363 |
73 | multicellular organismal water homeostasis (GO:0050891) | 4.02962202 |
74 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.99777033 |
75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96602920 |
76 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.95207583 |
77 | surfactant homeostasis (GO:0043129) | 3.94372905 |
78 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.92710817 |
79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.92477817 |
80 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.90554051 |
81 | endothelial cell chemotaxis (GO:0035767) | 3.90026589 |
82 | positive regulation of macrophage cytokine production (GO:0060907) | 3.85507534 |
83 | positive regulation of response to biotic stimulus (GO:0002833) | 3.84461336 |
84 | positive regulation of interleukin-10 production (GO:0032733) | 3.82943357 |
85 | intermediate filament organization (GO:0045109) | 3.82191391 |
86 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.81825125 |
87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.78307989 |
88 | T-helper cell differentiation (GO:0042093) | 3.77103260 |
89 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.77103260 |
90 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.76135572 |
91 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.75485287 |
92 | lymphocyte chemotaxis (GO:0048247) | 3.75226089 |
93 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.74245769 |
94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.74108837 |
95 | cellular response to interferon-beta (GO:0035458) | 3.73129073 |
96 | adhesion of symbiont to host (GO:0044406) | 3.70468830 |
97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.70012233 |
98 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.67413690 |
99 | regulation of monocyte chemotaxis (GO:0090025) | 3.67274419 |
100 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.67165121 |
101 | T cell migration (GO:0072678) | 3.63033638 |
102 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62899745 |
103 | regulation of interleukin-17 production (GO:0032660) | 3.61821347 |
104 | female mating behavior (GO:0060180) | 3.57467105 |
105 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.56921894 |
106 | positive regulation of activated T cell proliferation (GO:0042104) | 3.55843519 |
107 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.54218197 |
108 | regulation of interleukin-12 production (GO:0032655) | 3.53706624 |
109 | water homeostasis (GO:0030104) | 3.53335283 |
110 | intestinal epithelial cell development (GO:0060576) | 3.52917030 |
111 | natural killer cell activation involved in immune response (GO:0002323) | 3.49971234 |
112 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49096538 |
113 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.48603262 |
114 | nucleotide transport (GO:0006862) | 3.47726090 |
115 | regulation of type 2 immune response (GO:0002828) | 3.47569218 |
116 | keratinocyte differentiation (GO:0030216) | 3.46996215 |
117 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.43215658 |
118 | positive regulation of interleukin-2 production (GO:0032743) | 3.40242856 |
119 | regulation of defense response to virus by host (GO:0050691) | 3.40023209 |
120 | B cell mediated immunity (GO:0019724) | 3.38633343 |
121 | regulation of T cell migration (GO:2000404) | 3.38086952 |
122 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35209343 |
123 | glomerular filtration (GO:0003094) | 3.34851246 |
124 | negative regulation of cell-matrix adhesion (GO:0001953) | 3.33379386 |
125 | positive regulation of T cell chemotaxis (GO:0010820) | 3.32157914 |
126 | regulation of T cell chemotaxis (GO:0010819) | 3.32157914 |
127 | neuron projection regeneration (GO:0031102) | 3.30275825 |
128 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27665898 |
129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26646809 |
130 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.23417026 |
131 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.23417026 |
132 | T cell differentiation involved in immune response (GO:0002292) | 3.23417026 |
133 | positive regulation of prostaglandin secretion (GO:0032308) | 3.22775407 |
134 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22060080 |
135 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.22016186 |
136 | positive regulation of cell fate commitment (GO:0010455) | 3.20788152 |
137 | keratinocyte proliferation (GO:0043616) | 3.20078336 |
138 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.20008605 |
139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18993676 |
140 | neutrophil activation (GO:0042119) | 3.16143452 |
141 | type I interferon signaling pathway (GO:0060337) | 3.15993077 |
142 | cellular response to type I interferon (GO:0071357) | 3.15993077 |
143 | renal filtration (GO:0097205) | 3.15509260 |
144 | positive regulation of interferon-beta production (GO:0032728) | 3.15236350 |
145 | positive regulation of epidermis development (GO:0045684) | 3.15011015 |
146 | positive regulation of natural killer cell activation (GO:0032816) | 3.14549581 |
147 | fatty acid elongation (GO:0030497) | 3.13168532 |
148 | axon development (GO:0061564) | 3.12026949 |
149 | response to muramyl dipeptide (GO:0032495) | 3.11968442 |
150 | chemical homeostasis within a tissue (GO:0048875) | 3.11307018 |
151 | growth hormone receptor signaling pathway (GO:0060396) | 3.10695123 |
152 | response to type I interferon (GO:0034340) | 3.10253757 |
153 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08046057 |
154 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.07771777 |
155 | myeloid dendritic cell differentiation (GO:0043011) | 3.07704551 |
156 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.07396555 |
157 | regulation of chemokine biosynthetic process (GO:0045073) | 3.06630855 |
158 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.05546111 |
159 | granulocyte activation (GO:0036230) | 3.05406677 |
160 | negative regulation of interleukin-10 production (GO:0032693) | 3.04973378 |
161 | positive regulation of tissue remodeling (GO:0034105) | 3.04956881 |
162 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04741321 |
163 | cellular response to interferon-gamma (GO:0071346) | 3.04211656 |
164 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.03698485 |
165 | monocyte chemotaxis (GO:0002548) | 3.02539215 |
166 | regulation of cellular extravasation (GO:0002691) | 3.01905541 |
167 | epidermis development (GO:0008544) | 2.99928069 |
168 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.97675899 |
169 | tissue regeneration (GO:0042246) | 2.90820373 |
170 | positive regulation of cholesterol efflux (GO:0010875) | 2.89331221 |
171 | angiotensin maturation (GO:0002003) | 2.88749420 |
172 | epidermal cell differentiation (GO:0009913) | 2.88621256 |
173 | one-carbon compound transport (GO:0019755) | 2.87433829 |
174 | keratinocyte development (GO:0003334) | 2.81790598 |
175 | positive regulation of sterol transport (GO:0032373) | 2.78391272 |
176 | positive regulation of cholesterol transport (GO:0032376) | 2.78391272 |
177 | keratan sulfate catabolic process (GO:0042340) | 2.75925463 |
178 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.75508426 |
179 | tissue homeostasis (GO:0001894) | 2.75375205 |
180 | hair follicle morphogenesis (GO:0031069) | 2.71931763 |
181 | primary alcohol metabolic process (GO:0034308) | 2.69022113 |
182 | cellular response to growth hormone stimulus (GO:0071378) | 2.67517975 |
183 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.65208274 |
184 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63756707 |
185 | lung lobe morphogenesis (GO:0060463) | 2.60168468 |
186 | digestive system process (GO:0022600) | 2.59628365 |
187 | regulation of epidermal cell differentiation (GO:0045604) | 2.59590633 |
188 | hemidesmosome assembly (GO:0031581) | 2.56580870 |
189 | regulation of lymphocyte migration (GO:2000401) | 2.55742491 |
190 | Rap protein signal transduction (GO:0032486) | 2.52753983 |
191 | intermediate filament cytoskeleton organization (GO:0045104) | 2.52308920 |
192 | negative regulation of cell-substrate adhesion (GO:0010812) | 2.50075181 |
193 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.49475666 |
194 | carnitine metabolic process (GO:0009437) | 2.48843140 |
195 | epithelial structure maintenance (GO:0010669) | 2.44471141 |
196 | face development (GO:0060324) | 2.42211217 |
197 | intermediate filament-based process (GO:0045103) | 2.41754618 |
198 | biomineral tissue development (GO:0031214) | 2.38419298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.86288052 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.68147934 |
3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 6.57848674 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.29708776 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61668773 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.61486911 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.57407162 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.33360959 |
9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.93065287 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90264419 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71583193 |
12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.67785224 |
13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.52155523 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.45654975 |
15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28231777 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16274607 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10267063 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.08920586 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.88380081 |
20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.71772507 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67840841 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44677806 |
23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.34792929 |
24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.31134206 |
25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.26855901 |
26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20461262 |
27 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18145391 |
28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.14154363 |
29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.01526784 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90850571 |
31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90075151 |
32 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.88912834 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81154707 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80934770 |
35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80710996 |
36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79684239 |
37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76418506 |
38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.76212002 |
39 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.74926491 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74859834 |
41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73827147 |
42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.71714847 |
43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.71109354 |
44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71032075 |
45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70706605 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.70587371 |
47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69130508 |
48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.68751143 |
49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.65860916 |
50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64454441 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63925959 |
52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.63653263 |
53 | MYB_26560356_Chip-Seq_TH2_Human | 1.58787647 |
54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58320529 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56966186 |
56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56826927 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56813267 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51994239 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51127839 |
60 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.50504070 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47349318 |
62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.46924322 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44915971 |
64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44481355 |
65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41219666 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39181987 |
67 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38492562 |
68 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.33624017 |
69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32023720 |
70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30692661 |
71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30583407 |
72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29690615 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.28240790 |
74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27667236 |
75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24757602 |
76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22161393 |
77 | MAF_26560356_Chip-Seq_TH1_Human | 1.21778368 |
78 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20024487 |
79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19809131 |
80 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16729562 |
81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15609940 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15252231 |
83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13007353 |
84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12687274 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12687274 |
86 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10143011 |
87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09000911 |
88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08931064 |
89 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07849861 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.07681319 |
91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07371289 |
92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06536928 |
93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05257981 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04817589 |
95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04429118 |
96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04240776 |
97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04111500 |
98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04030632 |
99 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03889050 |
100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03852228 |
101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03480315 |
102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02966533 |
103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01757211 |
104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01463192 |
105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00962966 |
106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00870241 |
107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00869263 |
108 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00867267 |
109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00511595 |
110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00511595 |
111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00361431 |
112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00279092 |
113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99554163 |
114 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98651108 |
115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98620661 |
116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96806707 |
117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95019607 |
118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94319449 |
119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93214667 |
120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92545682 |
121 | MYB_26560356_Chip-Seq_TH1_Human | 0.91507808 |
122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90705730 |
123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86857470 |
124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86168300 |
125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83247062 |
126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83241634 |
127 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82842373 |
128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81256781 |
129 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81033824 |
130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.78864814 |
131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78776941 |
132 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78549806 |
133 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77447327 |
134 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.76799249 |
135 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.74162601 |
136 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.72725211 |
137 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.71683373 |
138 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.70251621 |
139 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.69096034 |
140 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.69096034 |
141 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67854019 |
142 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67828864 |
143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67616133 |
144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66642979 |
145 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65998302 |
146 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.65533769 |
147 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.64852000 |
148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.63412828 |
149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.62575696 |
150 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.61966706 |
151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61311778 |
152 | CJUN_26792858_Chip-Seq_BT549_Human | 0.58291523 |
153 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.58065647 |
154 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58040872 |
155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.55439799 |
156 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.54010558 |
157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.53385189 |
158 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.52681891 |
159 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.52654681 |
160 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.51891763 |
161 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51700266 |
162 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.51532687 |
163 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.51096817 |
164 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.51096097 |
165 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.51060068 |
166 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.50521372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005275_abnormal_skin_tensile | 6.57399409 |
2 | MP0001835_abnormal_antigen_presentation | 5.37036249 |
3 | MP0002796_impaired_skin_barrier | 5.12601746 |
4 | MP0009785_altered_susceptibility_to | 5.05832576 |
5 | MP0002148_abnormal_hypersensitivity_rea | 4.51736629 |
6 | MP0003183_abnormal_peptide_metabolism | 4.51249434 |
7 | MP0005671_abnormal_response_to | 4.03800408 |
8 | MP0003436_decreased_susceptibility_to | 3.71845154 |
9 | MP0010234_abnormal_vibrissa_follicle | 3.71786133 |
10 | MP0004510_myositis | 3.37093988 |
11 | MP0005025_abnormal_response_to | 3.30110690 |
12 | MP0005000_abnormal_immune_tolerance | 3.23473404 |
13 | MP0000685_abnormal_immune_system | 3.19884484 |
14 | MP0002419_abnormal_innate_immunity | 3.11605951 |
15 | MP0006082_CNS_inflammation | 3.10041090 |
16 | MP0005503_abnormal_tendon_morphology | 2.93181842 |
17 | MP0002098_abnormal_vibrissa_morphology | 2.82881829 |
18 | MP0002009_preneoplasia | 2.81154933 |
19 | MP0003724_increased_susceptibility_to | 2.65578498 |
20 | MP0001853_heart_inflammation | 2.63995698 |
21 | MP0002452_abnormal_antigen_presenting | 2.52464134 |
22 | MP0005501_abnormal_skin_physiology | 2.51901517 |
23 | MP0001790_abnormal_immune_system | 2.51519906 |
24 | MP0005387_immune_system_phenotype | 2.51519906 |
25 | MP0001800_abnormal_humoral_immune | 2.50201568 |
26 | MP0004264_abnormal_extraembryonic_tissu | 2.42718831 |
27 | MP0002060_abnormal_skin_morphology | 2.38414354 |
28 | MP0002723_abnormal_immune_serum | 2.37266103 |
29 | MP0005310_abnormal_salivary_gland | 2.25906575 |
30 | MP0005167_abnormal_blood-brain_barrier | 2.22491503 |
31 | MP0009764_decreased_sensitivity_to | 2.18313645 |
32 | MP0000647_abnormal_sebaceous_gland | 2.15178248 |
33 | MP0009780_abnormal_chondrocyte_physiolo | 2.11270797 |
34 | MP0003690_abnormal_glial_cell | 2.10713483 |
35 | MP0003303_peritoneal_inflammation | 2.09635048 |
36 | MP0001819_abnormal_immune_cell | 2.08503443 |
37 | MP0002138_abnormal_hepatobiliary_system | 2.08259266 |
38 | MP0008438_abnormal_cutaneous_collagen | 2.05006183 |
39 | MP0000579_abnormal_nail_morphology | 2.04955701 |
40 | MP0002420_abnormal_adaptive_immunity | 2.03019757 |
41 | MP0002006_tumorigenesis | 2.01561914 |
42 | MP0003075_altered_response_to | 2.01223310 |
43 | MP0005670_abnormal_white_adipose | 2.00847602 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.99343580 |
45 | MP0004381_abnormal_hair_follicle | 1.96638518 |
46 | MP0000377_abnormal_hair_follicle | 1.89768806 |
47 | MP0001348_abnormal_lacrimal_gland | 1.89476031 |
48 | MP0003448_altered_tumor_morphology | 1.89330444 |
49 | MP0003279_aneurysm | 1.89235504 |
50 | MP0010155_abnormal_intestine_physiology | 1.89106375 |
51 | MP0000467_abnormal_esophagus_morphology | 1.87755004 |
52 | MP0002254_reproductive_system_inflammat | 1.86742074 |
53 | MP0001845_abnormal_inflammatory_respons | 1.86079246 |
54 | MP0001533_abnormal_skeleton_physiology | 1.85764127 |
55 | MP0001216_abnormal_epidermal_layer | 1.82173129 |
56 | MP0002405_respiratory_system_inflammati | 1.79882045 |
57 | MP0008469_abnormal_protein_level | 1.71757136 |
58 | MP0005166_decreased_susceptibility_to | 1.67449806 |
59 | MP0002108_abnormal_muscle_morphology | 1.64632963 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.58027669 |
61 | MP0000604_amyloidosis | 1.53143348 |
62 | MP0004947_skin_inflammation | 1.48687322 |
63 | MP0000569_abnormal_digit_pigmentation | 1.48231245 |
64 | MP0010678_abnormal_skin_adnexa | 1.43549022 |
65 | MP0000858_altered_metastatic_potential | 1.41245870 |
66 | MP0002876_abnormal_thyroid_physiology | 1.40934802 |
67 | MP0010771_integument_phenotype | 1.39823604 |
68 | MP0000343_altered_response_to | 1.37845349 |
69 | MP0003828_pulmonary_edema | 1.36739511 |
70 | MP0009763_increased_sensitivity_to | 1.35703491 |
71 | MP0002282_abnormal_trachea_morphology | 1.33142967 |
72 | MP0000716_abnormal_immune_system | 1.32642839 |
73 | MP0004036_abnormal_muscle_relaxation | 1.29578848 |
74 | MP0002166_altered_tumor_susceptibility | 1.27991529 |
75 | MP0005164_abnormal_response_to | 1.26208855 |
76 | MP0006138_congestive_heart_failure | 1.23950396 |
77 | MP0005464_abnormal_platelet_physiology | 1.23684919 |
78 | MP0005397_hematopoietic_system_phenotyp | 1.23677320 |
79 | MP0001545_abnormal_hematopoietic_system | 1.23677320 |
80 | MP0003705_abnormal_hypodermis_morpholog | 1.21545419 |
81 | MP0002398_abnormal_bone_marrow | 1.19094908 |
82 | MP0004084_abnormal_cardiac_muscle | 1.18985683 |
83 | MP0000678_abnormal_parathyroid_gland | 1.16924355 |
84 | MP0002998_abnormal_bone_remodeling | 1.16504398 |
85 | MP0000383_abnormal_hair_follicle | 1.10716903 |
86 | MP0001243_abnormal_dermal_layer | 1.09928298 |
87 | MP0004043_abnormal_pH_regulation | 1.08456025 |
88 | MP0002877_abnormal_melanocyte_morpholog | 1.07583209 |
89 | MP0002163_abnormal_gland_morphology | 1.06153674 |
90 | MP0009931_abnormal_skin_appearance | 1.05271168 |
91 | MP0000767_abnormal_smooth_muscle | 1.03935020 |
92 | MP0009765_abnormal_xenobiotic_induced | 1.02905285 |
93 | MP0000367_abnormal_coat/_hair | 1.02801142 |
94 | MP0003941_abnormal_skin_development | 1.02604518 |
95 | MP0004883_abnormal_blood_vessel | 1.02563543 |
96 | MP0005666_abnormal_adipose_tissue | 1.02211196 |
97 | MP0001346_abnormal_lacrimal_gland | 0.98133177 |
98 | MP0000689_abnormal_spleen_morphology | 0.97812255 |
99 | MP0005248_abnormal_Harderian_gland | 0.96331112 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.96170952 |
101 | MP0005508_abnormal_skeleton_morphology | 0.95943919 |
102 | MP0002429_abnormal_blood_cell | 0.92889654 |
103 | MP0003329_amyloid_beta_deposits | 0.92882154 |
104 | MP0010386_abnormal_urinary_bladder | 0.92174561 |
105 | MP0002722_abnormal_immune_system | 0.88966700 |
106 | MP0001958_emphysema | 0.88954122 |
107 | MP0000566_synostosis | 0.88448706 |
108 | MP0003868_abnormal_feces_composition | 0.87206844 |
109 | MP0001542_abnormal_bone_strength | 0.86714279 |
110 | MP0000762_abnormal_tongue_morphology | 0.85661870 |
111 | MP0002933_joint_inflammation | 0.84390111 |
112 | MP0004019_abnormal_vitamin_homeostasis | 0.84367266 |
113 | MP0005023_abnormal_wound_healing | 0.83797051 |
114 | MP0005647_abnormal_sex_gland | 0.82295592 |
115 | MP0010307_abnormal_tumor_latency | 0.81778328 |
116 | MP0000249_abnormal_blood_vessel | 0.81586035 |
117 | MP0005390_skeleton_phenotype | 0.81432262 |
118 | MP0003638_abnormal_response/metabolism_ | 0.80605089 |
119 | MP0005451_abnormal_body_composition | 0.80563130 |
120 | MP0004885_abnormal_endolymph | 0.80399657 |
121 | MP0003186_abnormal_redox_activity | 0.78877851 |
122 | MP0000427_abnormal_hair_cycle | 0.78010811 |
123 | MP0000613_abnormal_salivary_gland | 0.77876337 |
124 | MP0001727_abnormal_embryo_implantation | 0.77373359 |
125 | MP0003300_gastrointestinal_ulcer | 0.76222734 |
126 | MP0000751_myopathy | 0.75620907 |
127 | MP0002938_white_spotting | 0.75080094 |
128 | MP0005058_abnormal_lysosome_morphology | 0.74244944 |
129 | MP0000920_abnormal_myelination | 0.73070415 |
130 | MP0000750_abnormal_muscle_regeneration | 0.72316741 |
131 | MP0002896_abnormal_bone_mineralization | 0.72218654 |
132 | MP0000465_gastrointestinal_hemorrhage | 0.71695053 |
133 | MP0002295_abnormal_pulmonary_circulatio | 0.69850646 |
134 | MP0003938_abnormal_ear_development | 0.68596535 |
135 | MP0000627_abnormal_mammary_gland | 0.67999874 |
136 | MP0002136_abnormal_kidney_physiology | 0.67860774 |
137 | MP0001756_abnormal_urination | 0.67577843 |
138 | MP0003091_abnormal_cell_migration | 0.67186134 |
139 | MP0005375_adipose_tissue_phenotype | 0.67017390 |
140 | MP0003866_abnormal_defecation | 0.66382677 |
141 | MP0008004_abnormal_stomach_pH | 0.65916482 |
142 | MP0004782_abnormal_surfactant_physiolog | 0.64245253 |
143 | MP0005409_darkened_coat_color | 0.63535561 |
144 | MP0008057_abnormal_DNA_replication | 0.63124494 |
145 | MP0001851_eye_inflammation | 0.63040198 |
146 | MP0002127_abnormal_cardiovascular_syste | 0.62533897 |
147 | MP0005076_abnormal_cell_differentiation | 0.60475238 |
148 | MP0001879_abnormal_lymphatic_vessel | 0.59197614 |
149 | MP0003936_abnormal_reproductive_system | 0.59119290 |
150 | MP0009379_abnormal_foot_pigmentation | 0.58873605 |
151 | MP0001191_abnormal_skin_condition | 0.57963643 |
152 | MP0002693_abnormal_pancreas_physiology | 0.57301195 |
153 | MP0001340_abnormal_eyelid_morphology | 0.56211047 |
154 | MP0003252_abnormal_bile_duct | 0.55802873 |
155 | MP0005330_cardiomyopathy | 0.55474625 |
156 | MP0001881_abnormal_mammary_gland | 0.55392696 |
157 | MP0005408_hypopigmentation | 0.54917316 |
158 | MP0005171_absent_coat_pigmentation | 0.54846597 |
159 | MP0003566_abnormal_cell_adhesion | 0.54593565 |
160 | MP0003045_fibrosis | 0.54113005 |
161 | MP0002168_other_aberrant_phenotype | 0.53462600 |
162 | MP0003656_abnormal_erythrocyte_physiolo | 0.53422616 |
163 | MP0000470_abnormal_stomach_morphology | 0.52694753 |
164 | MP0003633_abnormal_nervous_system | 0.51439806 |
165 | MP0003763_abnormal_thymus_physiology | 0.49607796 |
166 | MP0009840_abnormal_foam_cell | 0.48656285 |
167 | MP0004130_abnormal_muscle_cell | 0.48464137 |
168 | MP0002277_abnormal_respiratory_mucosa | 0.48435502 |
169 | MP0000371_diluted_coat_color | 0.47247256 |
170 | MP0003795_abnormal_bone_structure | 0.45153790 |
171 | MP0009278_abnormal_bone_marrow | 0.44337332 |
172 | MP0003631_nervous_system_phenotype | 0.43755676 |
173 | MP0008874_decreased_physiological_sensi | 0.43440363 |
174 | MP0005083_abnormal_biliary_tract | 0.41783976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Gastrointestinal infarctions (HP:0005244) | 7.68122411 |
2 | Systemic lupus erythematosus (HP:0002725) | 7.08039248 |
3 | Recurrent abscess formation (HP:0002722) | 6.84581018 |
4 | Recurrent bacterial skin infections (HP:0005406) | 6.69617930 |
5 | Abnormality of nail color (HP:0100643) | 6.44961567 |
6 | Eczematoid dermatitis (HP:0000976) | 5.99418722 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.88281526 |
8 | Woolly hair (HP:0002224) | 5.71339595 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.50754431 |
10 | Right ventricular cardiomyopathy (HP:0011663) | 5.45025276 |
11 | Hypotrichosis (HP:0001006) | 5.16272090 |
12 | Pili torti (HP:0003777) | 5.03595635 |
13 | Increased IgE level (HP:0003212) | 4.98017595 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 4.79751362 |
15 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.49286986 |
16 | Vasculitis (HP:0002633) | 4.46414397 |
17 | Lip pit (HP:0100267) | 4.43678288 |
18 | Breast carcinoma (HP:0003002) | 4.35578053 |
19 | Increased IgM level (HP:0003496) | 4.33414337 |
20 | Recurrent skin infections (HP:0001581) | 4.22485497 |
21 | Retrobulbar optic neuritis (HP:0100654) | 4.16089183 |
22 | Optic neuritis (HP:0100653) | 4.16089183 |
23 | Onycholysis (HP:0001806) | 4.13500502 |
24 | Abnormality of secondary sexual hair (HP:0009888) | 4.12459025 |
25 | Abnormality of the axillary hair (HP:0100134) | 4.12459025 |
26 | Petechiae (HP:0000967) | 4.12357760 |
27 | Alopecia of scalp (HP:0002293) | 4.03959818 |
28 | Pulmonary artery stenosis (HP:0004415) | 4.01721037 |
29 | Gingivitis (HP:0000230) | 3.87360668 |
30 | Orchitis (HP:0100796) | 3.84464619 |
31 | Myositis (HP:0100614) | 3.72591000 |
32 | Abnormality of hair growth rate (HP:0011363) | 3.72000663 |
33 | Slow-growing hair (HP:0002217) | 3.72000663 |
34 | Thick nail (HP:0001805) | 3.66532901 |
35 | Abnormality of complement system (HP:0005339) | 3.61380664 |
36 | Pustule (HP:0200039) | 3.59922594 |
37 | Basal ganglia calcification (HP:0002135) | 3.57535812 |
38 | Palmoplantar hyperkeratosis (HP:0000972) | 3.53553607 |
39 | Follicular hyperkeratosis (HP:0007502) | 3.50509022 |
40 | Amaurosis fugax (HP:0100576) | 3.47684707 |
41 | Hemoptysis (HP:0002105) | 3.46467558 |
42 | Ependymoma (HP:0002888) | 3.44861502 |
43 | Purpura (HP:0000979) | 3.42024631 |
44 | Hypertensive crisis (HP:0100735) | 3.38703891 |
45 | Brittle hair (HP:0002299) | 3.32697671 |
46 | Recurrent fungal infections (HP:0002841) | 3.29002628 |
47 | Gangrene (HP:0100758) | 3.28794245 |
48 | Stomach cancer (HP:0012126) | 3.28409990 |
49 | Palmar hyperkeratosis (HP:0010765) | 3.27886381 |
50 | Abnormal hair laboratory examination (HP:0003328) | 3.24426163 |
51 | Erythroderma (HP:0001019) | 3.22590484 |
52 | Anorexia (HP:0002039) | 3.20141868 |
53 | Periodontitis (HP:0000704) | 3.19322906 |
54 | Interstitial pulmonary disease (HP:0006530) | 3.18347294 |
55 | Vascular tortuosity (HP:0004948) | 3.17956079 |
56 | Hypokinesia (HP:0002375) | 3.17656278 |
57 | Abnormality of macrophages (HP:0004311) | 3.16630829 |
58 | Chest pain (HP:0100749) | 3.10691418 |
59 | Poor head control (HP:0002421) | 3.03779409 |
60 | Erythema (HP:0010783) | 3.03458191 |
61 | Plantar hyperkeratosis (HP:0007556) | 3.01162600 |
62 | Glomerulonephritis (HP:0000099) | 3.00466640 |
63 | Oral leukoplakia (HP:0002745) | 3.00255732 |
64 | Pulmonary infiltrates (HP:0002113) | 2.99985190 |
65 | Prolonged neonatal jaundice (HP:0006579) | 2.95986728 |
66 | Recurrent viral infections (HP:0004429) | 2.94497648 |
67 | Stomatitis (HP:0010280) | 2.92882522 |
68 | Hypergammaglobulinemia (HP:0010702) | 2.90649217 |
69 | Recurrent bronchitis (HP:0002837) | 2.89311052 |
70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88529104 |
71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88529104 |
72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88529104 |
73 | Autoimmune thrombocytopenia (HP:0001973) | 2.85013398 |
74 | Arterial tortuosity (HP:0005116) | 2.84901669 |
75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84111053 |
76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84111053 |
77 | Aortic aneurysm (HP:0004942) | 2.81292227 |
78 | Nail dystrophy (HP:0008404) | 2.79569754 |
79 | Nephritis (HP:0000123) | 2.78851188 |
80 | Axonal loss (HP:0003447) | 2.74368268 |
81 | Porencephaly (HP:0002132) | 2.74148384 |
82 | Arterial thrombosis (HP:0004420) | 2.74061720 |
83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.73806695 |
84 | Spontaneous abortion (HP:0005268) | 2.72654471 |
85 | Abnormal cartilage morphology (HP:0002763) | 2.71074335 |
86 | Abnormality of the pericardium (HP:0001697) | 2.69490955 |
87 | Sparse lateral eyebrow (HP:0005338) | 2.67318216 |
88 | Lower limb hyperreflexia (HP:0002395) | 2.64047414 |
89 | Keratoconjunctivitis sicca (HP:0001097) | 2.61710917 |
90 | Obstructive lung disease (HP:0006536) | 2.60050464 |
91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60050464 |
92 | Abnormality of the dental root (HP:0006486) | 2.53820818 |
93 | Taurodontia (HP:0000679) | 2.53820818 |
94 | Abnormality of permanent molar morphology (HP:0011071) | 2.53820818 |
95 | Pigmentary retinal degeneration (HP:0001146) | 2.53140721 |
96 | Recurrent pneumonia (HP:0006532) | 2.52859121 |
97 | Vacuolated lymphocytes (HP:0001922) | 2.50808871 |
98 | Peritonitis (HP:0002586) | 2.48672310 |
99 | Hemorrhage of the eye (HP:0011885) | 2.48104132 |
100 | Joint swelling (HP:0001386) | 2.47976834 |
101 | Absent eyelashes (HP:0000561) | 2.47531911 |
102 | Ectropion (HP:0000656) | 2.45144960 |
103 | Cellulitis (HP:0100658) | 2.45129863 |
104 | Osteolytic defects of the hand bones (HP:0009699) | 2.44709030 |
105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44709030 |
106 | Abnormality of molar (HP:0011077) | 2.43748929 |
107 | Abnormality of molar morphology (HP:0011070) | 2.43748929 |
108 | Sparse eyelashes (HP:0000653) | 2.43267966 |
109 | Gingival bleeding (HP:0000225) | 2.43255489 |
110 | Distal lower limb muscle weakness (HP:0009053) | 2.40098010 |
111 | Conjunctival hamartoma (HP:0100780) | 2.39436426 |
112 | Keratoconjunctivitis (HP:0001096) | 2.39356505 |
113 | Abnormality of the dental pulp (HP:0006479) | 2.37960906 |
114 | Vertebral compression fractures (HP:0002953) | 2.37590414 |
115 | Arthralgia (HP:0002829) | 2.37298159 |
116 | Chronic sinusitis (HP:0011109) | 2.37050994 |
117 | Cerebral ischemia (HP:0002637) | 2.37016102 |
118 | Tetraparesis (HP:0002273) | 2.33563000 |
119 | Abnormality of the pleura (HP:0002103) | 2.33180951 |
120 | Urticaria (HP:0001025) | 2.33132745 |
121 | Aplasia cutis congenita (HP:0001057) | 2.32420412 |
122 | Meningitis (HP:0001287) | 2.30658735 |
123 | Mitral stenosis (HP:0001718) | 2.29904385 |
124 | Autoamputation (HP:0001218) | 2.27556700 |
125 | Absent hair (HP:0002298) | 2.25251694 |
126 | Aortic dissection (HP:0002647) | 2.24511762 |
127 | Leukocytosis (HP:0001974) | 2.24215563 |
128 | Myocardial infarction (HP:0001658) | 2.21306258 |
129 | Alveolar cell carcinoma (HP:0006519) | 2.19954132 |
130 | Hypohidrosis (HP:0000966) | 2.17690978 |
131 | Bronchitis (HP:0012387) | 2.16964071 |
132 | Premature loss of primary teeth (HP:0006323) | 2.16820844 |
133 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16141428 |
134 | Frequent falls (HP:0002359) | 2.14370270 |
135 | Skin ulcer (HP:0200042) | 2.13806958 |
136 | Abnormality of the astrocytes (HP:0100707) | 2.13649146 |
137 | Astrocytoma (HP:0009592) | 2.13649146 |
138 | Acanthosis nigricans (HP:0000956) | 2.13188753 |
139 | Abnormality of T cell number (HP:0011839) | 2.11684524 |
140 | Palmoplantar keratoderma (HP:0000982) | 2.11408374 |
141 | Increased connective tissue (HP:0009025) | 2.10832885 |
142 | Cerebral aneurysm (HP:0004944) | 2.10520952 |
143 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10173631 |
144 | Disinhibition (HP:0000734) | 2.07404585 |
145 | Hyporeflexia of lower limbs (HP:0002600) | 2.07385230 |
146 | Corneal erosion (HP:0200020) | 2.05460124 |
147 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.04784262 |
148 | Villous atrophy (HP:0011473) | 2.04784262 |
149 | Complement deficiency (HP:0004431) | 2.04777708 |
150 | Germ cell neoplasia (HP:0100728) | 2.04566724 |
151 | Deep philtrum (HP:0002002) | 2.03775839 |
152 | Natal tooth (HP:0000695) | 2.03736093 |
153 | Abnormality of the endocardium (HP:0004306) | 2.03703920 |
154 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02927884 |
155 | Severe Myopia (HP:0011003) | 2.02854660 |
156 | Progressive visual loss (HP:0000529) | 2.01975863 |
157 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00771706 |
158 | Abnormality of the basal ganglia (HP:0002134) | 2.00365759 |
159 | Autoimmune hemolytic anemia (HP:0001890) | 1.99997966 |
160 | Bulbar palsy (HP:0001283) | 1.98625449 |
161 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97561989 |
162 | Dehydration (HP:0001944) | 1.97512359 |
163 | Hematochezia (HP:0002573) | 1.96378303 |
164 | Amyloidosis (HP:0011034) | 1.95300214 |
165 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95260933 |
166 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95167090 |
167 | Nasal speech (HP:0001611) | 1.94890559 |
168 | Chondrocalcinosis (HP:0000934) | 1.93637307 |
169 | Chronic otitis media (HP:0000389) | 1.92563673 |
170 | Obstructive sleep apnea (HP:0002870) | 1.91316223 |
171 | Osteomyelitis (HP:0002754) | 1.90888000 |
172 | Cleft eyelid (HP:0000625) | 1.89744249 |
173 | Prostate neoplasm (HP:0100787) | 1.89672436 |
174 | Acrocyanosis (HP:0001063) | 1.89527831 |
175 | Abnormal blistering of the skin (HP:0008066) | 1.88607676 |
176 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.87029684 |
177 | Hamartoma of the eye (HP:0010568) | 1.86874609 |
178 | Heterochromia iridis (HP:0001100) | 1.86517383 |
179 | Abnormality of Sharpey fibers (HP:0100685) | 1.85844686 |
180 | Advanced eruption of teeth (HP:0006288) | 1.85419031 |
181 | Hepatosplenomegaly (HP:0001433) | 1.85007860 |
182 | Fine hair (HP:0002213) | 1.84811435 |
183 | Cerebral hemorrhage (HP:0001342) | 1.84811154 |
184 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.84787646 |
185 | Thin bony cortex (HP:0002753) | 1.83616887 |
186 | Seborrheic dermatitis (HP:0001051) | 1.81803584 |
187 | Sparse scalp hair (HP:0002209) | 1.78960827 |
188 | Ulnar claw (HP:0001178) | 1.78747751 |
189 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78216091 |
190 | Milia (HP:0001056) | 1.75495022 |
191 | Parakeratosis (HP:0001036) | 1.73489026 |
192 | Hypoplasia of the iris (HP:0007676) | 1.73377952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 5.81343365 |
2 | MAP3K14 | 4.96194798 |
3 | EPHA2 | 4.83694345 |
4 | RIPK4 | 4.16240444 |
5 | PIM2 | 4.01738710 |
6 | TBK1 | 3.59349898 |
7 | BRSK2 | 3.35978417 |
8 | TYK2 | 3.20556284 |
9 | NEK9 | 3.04496638 |
10 | IKBKB | 2.94399801 |
11 | RIPK1 | 2.92123623 |
12 | PBK | 2.85218120 |
13 | JAK3 | 2.60359107 |
14 | IRAK4 | 2.49747429 |
15 | FER | 2.25717533 |
16 | STK38L | 2.24940622 |
17 | JAK1 | 2.18894034 |
18 | PIK3CA | 2.11866350 |
19 | MAP4K1 | 2.10572549 |
20 | LATS1 | 2.10084310 |
21 | CHUK | 2.03095105 |
22 | MAPKAPK3 | 2.02772357 |
23 | IKBKE | 2.01921383 |
24 | TXK | 1.97263369 |
25 | IRAK3 | 1.87566803 |
26 | ERBB2 | 1.76018305 |
27 | MAPK15 | 1.74023807 |
28 | BMPR2 | 1.70343941 |
29 | PTK2 | 1.68063098 |
30 | TNK2 | 1.66000919 |
31 | MYLK | 1.61532498 |
32 | JAK2 | 1.49376479 |
33 | MAP3K6 | 1.44510870 |
34 | SIK3 | 1.41483916 |
35 | CDK12 | 1.41395897 |
36 | MST1R | 1.36576707 |
37 | ABL2 | 1.33288622 |
38 | SYK | 1.26818902 |
39 | PRKCI | 1.25487751 |
40 | DMPK | 1.24237212 |
41 | CDK6 | 1.24000234 |
42 | MAP3K3 | 1.20769934 |
43 | MST4 | 1.18124501 |
44 | STK4 | 1.17319139 |
45 | NME2 | 1.12997466 |
46 | BTK | 1.10885753 |
47 | ZAP70 | 1.09610018 |
48 | CLK1 | 1.07447788 |
49 | TGFBR2 | 1.07351368 |
50 | CSF1R | 1.06783303 |
51 | MAP3K5 | 1.05336913 |
52 | KIT | 1.04889400 |
53 | MAP3K13 | 1.03173964 |
54 | LATS2 | 0.98423928 |
55 | FES | 0.97086931 |
56 | HCK | 0.96772281 |
57 | LYN | 0.96445056 |
58 | PDGFRA | 0.94118787 |
59 | OXSR1 | 0.93670844 |
60 | PIM1 | 0.92862564 |
61 | DAPK3 | 0.91793805 |
62 | STK24 | 0.90869542 |
63 | BCR | 0.90162383 |
64 | MAP3K11 | 0.89748056 |
65 | ERBB3 | 0.89679689 |
66 | SCYL2 | 0.87446607 |
67 | FGR | 0.87183694 |
68 | DAPK2 | 0.87022524 |
69 | CSK | 0.86217445 |
70 | TEC | 0.85491110 |
71 | CASK | 0.85378817 |
72 | ARAF | 0.84206998 |
73 | DDR2 | 0.83981347 |
74 | CDK7 | 0.83824476 |
75 | LCK | 0.83803995 |
76 | EEF2K | 0.83661691 |
77 | EIF2AK3 | 0.83148744 |
78 | TESK1 | 0.81950841 |
79 | MAP3K4 | 0.81630103 |
80 | RET | 0.80427091 |
81 | TAOK3 | 0.78357691 |
82 | MET | 0.75910859 |
83 | MAP3K12 | 0.72803639 |
84 | EIF2AK2 | 0.72558874 |
85 | PRKCQ | 0.69621590 |
86 | GRK7 | 0.69454543 |
87 | SIK2 | 0.67779724 |
88 | PRKAA2 | 0.67143000 |
89 | ILK | 0.66647999 |
90 | DYRK1B | 0.66615200 |
91 | MAPK7 | 0.66187785 |
92 | BMX | 0.65071500 |
93 | YES1 | 0.64535957 |
94 | PRKCD | 0.63976190 |
95 | PRKD1 | 0.63881156 |
96 | STK38 | 0.63697947 |
97 | MARK3 | 0.63359621 |
98 | ABL1 | 0.62535295 |
99 | WEE1 | 0.61018752 |
100 | CAMKK2 | 0.59737108 |
101 | EPHB1 | 0.58865356 |
102 | EGFR | 0.58654903 |
103 | RPS6KB2 | 0.58174610 |
104 | OBSCN | 0.57270413 |
105 | FGFR3 | 0.57053732 |
106 | EPHA3 | 0.56237102 |
107 | CDC42BPA | 0.55716565 |
108 | FGFR4 | 0.54879914 |
109 | BRSK1 | 0.54217176 |
110 | ADRBK2 | 0.53336356 |
111 | CDK3 | 0.51264358 |
112 | TRPM7 | 0.50629109 |
113 | NUAK1 | 0.49217310 |
114 | MARK2 | 0.48995272 |
115 | ICK | 0.46890966 |
116 | TRIB3 | 0.45974246 |
117 | MTOR | 0.45811375 |
118 | GRK1 | 0.45766611 |
119 | SIK1 | 0.44530498 |
120 | PAK4 | 0.44456702 |
121 | TIE1 | 0.43165442 |
122 | LRRK2 | 0.41779542 |
123 | PKN1 | 0.41705752 |
124 | PIK3CG | 0.40081780 |
125 | RPS6KA2 | 0.39063237 |
126 | MAP2K6 | 0.38310718 |
127 | CSNK1E | 0.37745036 |
128 | MAPK3 | 0.37687904 |
129 | AKT3 | 0.37205805 |
130 | ROCK1 | 0.36787444 |
131 | SGK1 | 0.36626064 |
132 | MAPKAPK2 | 0.35714573 |
133 | MAPK9 | 0.34757845 |
134 | MAPK8 | 0.34487290 |
135 | STK3 | 0.34371704 |
136 | PKN2 | 0.33452639 |
137 | STK39 | 0.32857410 |
138 | ERN1 | 0.32474355 |
139 | ITK | 0.32028898 |
140 | PAK3 | 0.31816349 |
141 | DAPK1 | 0.31496817 |
142 | NTRK1 | 0.30513178 |
143 | WNK1 | 0.27740065 |
144 | CAMKK1 | 0.26200945 |
145 | FYN | 0.26101501 |
146 | SRC | 0.24652905 |
147 | PDK1 | 0.24517363 |
148 | MAPK4 | 0.22578266 |
149 | NTRK2 | 0.21733185 |
150 | PTK6 | 0.21179896 |
151 | PRKCE | 0.19220898 |
152 | MAP3K8 | 0.18392757 |
153 | IGF1R | 0.18293122 |
154 | TAOK1 | 0.17878265 |
155 | PTK2B | 0.17838822 |
156 | PRKCA | 0.17681184 |
157 | PDPK1 | 0.16693962 |
158 | NEK6 | 0.15726115 |
159 | PDGFRB | 0.15655626 |
160 | MATK | 0.15467661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 4.96225678 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.12526452 |
3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.83180992 |
4 | ABC transporters_Homo sapiens_hsa02010 | 3.60841288 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14925929 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.14058781 |
7 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.10616297 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.00035528 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.94404626 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.91074342 |
11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.77718316 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.76008937 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.74277595 |
14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.62187250 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.59894749 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.48195740 |
17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41564827 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20485697 |
19 | Malaria_Homo sapiens_hsa05144 | 2.20373041 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17086248 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12527979 |
22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10928603 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 2.09095421 |
24 | Measles_Homo sapiens_hsa05162 | 2.05714148 |
25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03776934 |
26 | Renin secretion_Homo sapiens_hsa04924 | 1.98122459 |
27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92752506 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.91688594 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86479137 |
30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86260542 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.83804707 |
32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74030103 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.65522663 |
34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63947921 |
35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.62622400 |
36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61573468 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55235998 |
38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53968568 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51132552 |
40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47355444 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46828103 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.44234496 |
43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.43109811 |
44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37746192 |
45 | Asthma_Homo sapiens_hsa05310 | 1.35225836 |
46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34665017 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30891980 |
48 | Prion diseases_Homo sapiens_hsa05020 | 1.29001322 |
49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28882319 |
50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28055842 |
51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24755120 |
52 | Apoptosis_Homo sapiens_hsa04210 | 1.23559806 |
53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22839556 |
54 | Amoebiasis_Homo sapiens_hsa05146 | 1.19524258 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12925731 |
56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09949286 |
57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07387561 |
58 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06836594 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04582453 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01864112 |
61 | Prostate cancer_Homo sapiens_hsa05215 | 0.99557880 |
62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97681097 |
63 | Adherens junction_Homo sapiens_hsa04520 | 0.94869216 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.94855121 |
65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93680373 |
66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90904319 |
67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88692066 |
68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88278083 |
69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87218016 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.82339583 |
71 | Focal adhesion_Homo sapiens_hsa04510 | 0.81826738 |
72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80224585 |
73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78135258 |
74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77968970 |
75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77054055 |
76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76974292 |
77 | Tight junction_Homo sapiens_hsa04530 | 0.74522159 |
78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73775158 |
79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72456183 |
80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71072845 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70624694 |
82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69616561 |
83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69278238 |
84 | Hepatitis B_Homo sapiens_hsa05161 | 0.69210410 |
85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69156300 |
86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68933267 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67263798 |
88 | Bladder cancer_Homo sapiens_hsa05219 | 0.66701167 |
89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65768868 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64440689 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62065502 |
92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60071221 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59171305 |
94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58972824 |
95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58658034 |
96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57161518 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56707698 |
98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56529916 |
99 | Peroxisome_Homo sapiens_hsa04146 | 0.55926259 |
100 | Hepatitis C_Homo sapiens_hsa05160 | 0.54492637 |
101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52332106 |
102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51973240 |
103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48796143 |
104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48715364 |
105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47489128 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46376850 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44939889 |
108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43166936 |
109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42024219 |
110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40452864 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40177993 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39642298 |
113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39634729 |
114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39396611 |
115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39259796 |
116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38406466 |
117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37959392 |
118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37380617 |
119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36396630 |
120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36189448 |
121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34313626 |
122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34098929 |
123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33226349 |
124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32940836 |
125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32277783 |
126 | Platelet activation_Homo sapiens_hsa04611 | 0.31680659 |
127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31369013 |
128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29204092 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28487738 |
130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25478431 |
131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24302079 |
132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24104360 |
133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22120811 |
134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17064574 |
135 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.16506977 |
136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16348444 |
137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13662551 |
138 | Mineral absorption_Homo sapiens_hsa04978 | 0.13447343 |
139 | Insulin resistance_Homo sapiens_hsa04931 | 0.13402296 |
140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12953992 |
141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12203392 |
142 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12114975 |
143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11003308 |
144 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.10897175 |
145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.10611390 |
146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10576235 |
147 | Histidine metabolism_Homo sapiens_hsa00340 | 0.10270700 |
148 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.10188927 |
149 | Endocytosis_Homo sapiens_hsa04144 | 0.10012073 |
150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.09215219 |
151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08720208 |
152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.08681168 |
153 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07343253 |
154 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.05877936 |
155 | Proteasome_Homo sapiens_hsa03050 | 0.05772028 |
156 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04966536 |
157 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.03975045 |
158 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03441266 |
159 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.03424052 |
160 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.02969178 |
161 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.02772666 |
162 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0077862 |
163 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0005553 |